SURMODICS INC
DelistedCIK 924717fmd_1HVCTEJWTT8TJBMEGXD1XTAS0SManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Oct 01, 2008 to Jun 30, 2025, 62 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 62 | 71 | 73 | 81 | 100 | 95 | 105 | 100 | 133 | 126 |
| Cost of revenue | 9 | 11 | 11 | 14 | 14 | 15 | 17 | 20 | 25 | 33 |
| Gross profit | 53 | 60 | 62 | 67 | 86 | 80 | 88 | 80 | 108 | 93 |
| Realized investment gains (losses) | – | – | – | – | – | – | – | – | – | – |
| Research and development | 16 | 18 | 32 | 41 | 53 | 50 | 47 | 51 | 47 | 38 |
| Selling, general and administrative | 15 | 18 | 20 | 24 | 24 | 28 | 31 | 47 | 52 | 57 |
| Operating income | 19 | 17 | 7 | (9) | 6 | (1) | 7 | (22) | 5 | (6) |
| Interest expense | – | – | – | – | 0 | 0 | 0 | 1 | 3 | 4 |
| Other non-operating income (expense) | (1) | 0 | (0) | 1 | 1 | (0) | (0) | (0) | (3) | (2) |
| Income before taxes | 18 | 17 | 7 | (8) | 8 | (1) | 6 | (22) | 2 | (8) |
| Income tax expense | 6 | 7 | 3 | (3) | (0) | (3) | 2 | 5 | 4 | 4 |
| Net income from continuing operations | 12 | 10 | 4 | (4) | 8 | 1 | 4 | (27) | (2) | (12) |
| Net income | 12 | 10 | 4 | (4) | 8 | 1 | 4 | (27) | (2) | (12) |